ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives

Angiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-transcriptional modulation...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Federica Saponaro, Grazia Rutigliano, Simona Sestito, Lavinia Bandini, Barbara Storti, Ranieri Bizzarri, Riccardo Zucchi
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2020-09-01
Серии:Frontiers in Molecular Biosciences
Предметы:
angiotensin-converting enzyme 2
ACE2 receptor
cardioprotection
COVID-19
SARS-CoV-2
spike protein
Online-ссылка:https://www.frontiersin.org/article/10.3389/fmolb.2020.588618/full
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы